Key role for activin B in cellular transformation after loss of the von Hippel-Lindau tumor suppressor.
Ontology highlight
ABSTRACT: The von Hippel-Lindau tumor suppressor gene (VHL) is mutated in clear cell renal cell carcinomas (RCC), leading to the activation of hypoxia-inducible factor (HIF)-mediated gene transcription. Several VHL/HIF targets, such as glycolysis, angiogenesis, cell growth, and chemotaxis of tumor cells, have been implicated in the transformed phenotype of RCC-regulating properties. Here, we show that VHL suppresses key features of cell transformation through downregulation of the HIF-dependent expression of activin B, a member of the transforming growth factor beta superfamily. Activin B expression is repressed by restoration of VHL in VHL-deficient RCC cells and upregulated by hypoxia. RCC tumor samples show increased expression of activin B compared to that in the normal kidney. VHL increases cel
SUBMITTER: Wacker I
PROVIDER: S-EPMC2655617 | biostudies-literature | 2009 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA